Fresenius SE KGaA (XTER:FRE) Marketable Securities: €1,890 Mil (As of Mar. 2026)


XTER:FRE Fresenius SE & Co KGaA XTER:FRE
67 GF Score
Price €42.12
GF Value €36.57
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Marketable Securities?

Fresenius SE KGaA XTER:FRE +2.66% 67 Marketable Securities is €1,890 Mil as of Mar. 2026. GuruFocus rates XTER:FRE with a GF Score™ of 67/100 and a GF Value™ of €36.57 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Fresenius SE KGaA's Marketable Securities for the quarter that ended in Mar. 2026 was €1,890 Mil.

Fresenius SE KGaA  (XTER:FRE) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Fresenius SE KGaA Marketable Securities Related Terms

Fresenius SE KGaA Marketable Securities Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Marketable Securities Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 136.00 0.00 0.00 0.00 0.00

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 143.00 165.00 152.00 0.00 1,890.00
XTER:FRE
67GF Score
Fresenius SE & Co KGaA XTER:FRE
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €1,890 Mil mean?
Fresenius SE KGaA (XTER:FRE) has a Marketable Securities of €1,890 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Fresenius SE KGaA and its competitors.
Is Fresenius SE KGaA's Marketable Securities too high?
Fresenius SE KGaA's current Marketable Securities is €1,890 Mil. Overall, Fresenius SE KGaA has a GF Score™ of 67/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Marketable Securities compare to HCA and THC?
Fresenius SE KGaA's Marketable Securities of €1,890 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Healthcare Providers & Services company?
A good Marketable Securities depends on the Healthcare Providers & Services industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Fresenius SE KGaA and its competitors. Fresenius SE KGaA's current Marketable Securities is €1,890 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Based on GuruFocus' analysis, Fresenius SE KGaA (XTER:FRE) is currently considered Modestly Overvalued. The stock's GF Value™ is €36.57, compared to a current price of €42.12 — trading 15.2% above its estimated fair value. The current Marketable Securities is €1,890 Mil. Fresenius SE KGaA's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Fresenius SE KGaA (XTER:FRE), the current Marketable Securities is €1,890 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XTER:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of €42.12 is trading 15.2% above its estimated GF Value™ of €36.57. GuruFocus considers Fresenius SE KGaA to be Modestly Overvalued.

Key valuation signals for XTER:FRE:

  • Marketable Securities: €1,890 Mil
  • GF Value™: €36.57 vs. price of €42.12 (15.2% above fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the XTER:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
67GF Score

Get the complete analysis for XTER:FRE

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€42.12
Price
€36.57
GF Value